Ginkgo Bioworks, Inc. (“Ginkgo”) today announced the signing of a program in a partnership with the Sumitomo Chemical Co., Ltd . (“Sumitomo Chemical”), one of Japan’s leading chemical companies. Ginkgo is building the leading horizontal platform for cell programming, to serve customers across industries seeking to develop better products.
| BOSTON, June 7, 2021 /PRNewswire/ -- Ginkgo Bioworks (“Ginkgo”) today announced the signing of a program in a partnership with the Sumitomo Chemical Company, Ltd. (“Sumitomo Chemical”), one of Japan’s leading chemical companies. Ginkgo is building the leading horizontal platform for cell programming, to serve customers across industries seeking to develop better products. Sumitomo Chemical seeks to leverage Ginkgo’s long-established expertise in organism engineering to significantly increase the production efficiency and sustainability of a key bio-based commercial product. As cell programming has evolved to become faster, more precise and cost-effective, companies across industries have been able to replace petroleum-based products, or optimize existing biology mediated manufacturing processes, through engineering microbial strains. Sumitomo Chemical was founded around a mission to drive societal impact and solve environmental challenges through technology, and the company has chosen to leverage Ginkgo’s extensive cell programming platform and biological codebase to explore next generation solutions as Sumitomo Chemical looks to utilize more bio-based production methods. “We’re proud to partner with Sumitomo Chemical and help them realize the potential of synthetic biology to deliver new, more sustainable and efficiently manufactured bio-based products to markets where innovation is an absolute imperative,” said Jason Kelly, CEO of Ginkgo Bioworks. “Sumitomo Chemical and Ginkgo are united by the shared belief in the power of biology to build a better future, and we’re excited to see what we can accomplish together.” “Ginkgo is unparalleled in organism design expertise, and we’re looking forward to combining their high-throughput genome editing and fermentation capabilities with our chemical technologies and industry insights in health and crop sciences,” said Hiroshi Ueda, CTO of Sumitomo Chemical. “Continued investment in synthetic biology will help us deliver to our customers more efficient and sustainable solutions across a myriad of industries.” Ginkgo Bioworks About Sumitomo Chemical Company Limited Media contact Investor contact
SOURCE Ginkgo Bioworks |
View original content:
